Navigation Links
Former Vice President of Development Operations at XenoPort, Sami Karaborni, PhD, joins NDA Partners as Expert Consultant
Date:6/5/2017

NDA Partners Chairman Carl Peck, MD, announced today that Sami Karaborni, PhD, senior pharmaceutical executive and former Vice President of Development Operations and Executive Director of Preformulations and Formulation Development at XenoPort Inc., has joined the firm as an Expert Consultant. Dr. Karaborni is an expert in product and process development of new chemical entities (NCEs) and various dosage forms. Over his impressive 20-year career in the pharmaceutical and chemical industries, he served in several senior executive positions. At XenoPort, he led multiple groups active in the areas of chemical, analytical, bioanalytical, formulation development, supply chain and commercial manufacturing. He was formerly Director of Pre-clinical Development Technology, Director of Materials Characterization and Technology Assessment, and Director of Formulation Design and Characterization at Merck Research Labs. In his early career, Senior Research Engineer for the Royal Dutch Shell company in Amsterdam, The Netherlands.

“Dr. Sami Karaborni’s career in the pharmaceutical and chemical industries and expertise in product and process development of new chemical entities will greatly enhance the industry perspective we are able to provide our clients in support of their CMC development programs,” said Dr. David Savello, Partner and Manager, Product Quality & CMC Practice. “We are very pleased to welcome him to NDA Partners.”

Dr. Karaborni earned his PhD and MS in Chemical Engineering from the University of Florida and his BS in Chemical Engineering from Pennsylvania State University. He is a member of the advisory board of the Surfactant Science series and inventor of 19 US published patents and patent applications. He is the (co)author of more than 40 publications in international journals among which Science (Washington), Nature (London), La Recherche Scientifique (Paris) and Mundo Científico (Madrid) and has been a key speaker in several conferences among which, Gordon Conferences (USA), Royal Society of Chemistry (Great Britain) and Rencontres de Moriond (Switzerland).

About NDA Partners
NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle(at)ndapartners(dot)com

Read the full story at http://www.prweb.com/releases/2017/06/prweb14382868.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Former CEO of Eurofins Advantar Laboratories, Richard Kenley, PhD, joins NDA Partners as Expert Consultant
2. Former FDA Official to Conduct Popular ComplianceOnline Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
3. Former P&G VP Appointed New Industry Expert at Verixs Advisory Board
4. Former Director of FDA Division of Biostatistics, Gregory Campbell, PhD, joins NDA Partners as Expert Consultant
5. Vinod Shah, PhD, Former Senior Research Scientist in FDA Office of Pharmaceutical Sciences, Joins NDA Partners as Expert Consultant
6. Former Allergan Chief David Pyott Signs on as Special Advisor to Sienna Biopharmaceuticals
7. Dr. Daniel Spyker, Former FDA acting Deputy Division Director of Cardiovascular, Respiratory, and Neurological Devices, Joins NDA Partners
8. Repetitive Head Injuries May Not Cause Movement Problems for Former NFL Players
9. Dr. Deborah Wenkert Pediatrics Expert and Former Amgen Clinical Research Medical Director, Joins NDA Partners
10. Dr. John Norris, Former 2nd-in-Command at the US FDA, Calls Out the Need for Several Types of FDA Reforms – And Tools to Implement Them
11. Dr. Steven Brooks, Former FDA Medical Officer, Peripheral Vascular Device Branch, Office of Device Evaluation, Joins NDA Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2019)... ... ... tech PR agency at the epicenter of the future of PR, today announced that it ... Ragan’s Health Care PR & Marketing Awards. This award marks the second consecutive year ARPR ... healthIT practice group grew by 18 percent in Q3 this year, driven by client renewals, ...
(Date:10/10/2019)... VEGAS (PRWEB) , ... October 10, 2019 , ... R3 ... courses. The next course is October 18-19th, 2019 in Las Vegas with spots still ... exosomes. He completed training at several Ivy League universities including Cornell, Harvard and Dartmouth. ...
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia ... therapy technology (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) ... laser for the temporary relief of chronic neck and shoulder pain of musculoskeletal ...
(Date:10/3/2019)... POWAY, Calif. (PRWEB) , ... October 01, 2019 , ... ... owner’s riding program. Mimi, Cheyenne’s owner, owns and operates Rebel’s Run , ... Cheyenne was a favorite amongst students and trail riding guests. Mimi describes her ...
Breaking Biology Technology:
(Date:10/26/2019)... ... , ... World Cord Blood Day (WCBD) takes place on November 15, 2019, ... the current and future uses of cord blood stem cells, and the potential cord ... and cure over 80 different life-threatening diseases, including leukemia, lymphoma, and sickle cell anemia. ...
(Date:10/26/2019)... (PRWEB) , ... October 24, 2019 , ... THE PRINCESS ... only been the standard choice for female providers, they were the only choice. Women ... the breasts, or a loose garment that can allow harmful radiation to penetrate the ...
(Date:10/26/2019)... , ... October 25, 2019 , ... ... on myofunctional therapy in La Plata, MD. Orofacial myofunctional disorders (OMDs) are abnormal ... eats, sleeps and speaks. This can include anything from difficulty swallowing and limited ...
Breaking Biology News(10 mins):